Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of the Probiotic Lactobacillus Reuteri in the Prevention of Antibiotic Associated-diarrhea and Clostridium Difficile Related Infections in Hospitalized Adult Patients

NCT02127814 is registered in ClinicalTrials.gov with Case Western Reserve University as lead sponsor.

NCT NCT02127814
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02127814 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of the Probiotic Lactobacillus Reuteri in the Prevention of Antibiotic Associated-diarrhea and Clostridium Difficile Related Infections in Hospitalized Adult Patients
Lead sponsor
Case Western Reserve University
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2010
Completion date
December 31, 2017
Enrollment
73 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antibiotic-associated diarrhea, clostridium difficile